Advertisement.

ETXPF Projected Dividend Yield

Ord/E-Therapeutics PLC ( OTCBB : ETXPF )

E-Therapeutics is engaged in computational drug discovery business. Co. constructs and analyse biological networks using its computer-based platform to give insight into disease mechanisms. Co.'s proprietary in silico platform incorporates data and a suite of computational tools that employ analytical techniques, including machine learning. Co. focuses on two Network-Driven Drug Discovery (NDD) derived assets in the immuno-oncology area: Tryptophan Catabolism and Immune Checkpoint Modulation. Co. also has commercial collaborations program. Co. is using its NDD approach to identify intervention strategies, biological pathways and compounds for its partner, Novo Nordisk for Type-2 diabetes.

20 YEAR PERFORMANCE RESULTS

ETXPF Dividend History Detail
ETXPF Dividend News
ETXPF Competitors News

# of Shares: 0

Closing Price: 0.13

Current Market Value: 0.00

Cost Basis: 0.00

Date Acquired:

Dividend Cash Flow
Year	Annual Dividend	Dividend Growth	# of Shares	Annual Dividend Income	Yield On Cost %
2014	0.00	0%	0	$ 0.00	0.00%
2015	0.00	0%	0	$ 0.00	0.00%
2016	0.00	0%	0	$ 0.00	0.00%
2017	0.00	0%	0	$ 0.00	0.00%
2018	0.00	0%	0	$ 0.00	0.00%
2019	0.00	0%	0	$ 0.00	0.00%
2020	0.00	0%	0	$ 0.00	0.00%
2021	0.00	0%	0	$ 0.00	0.00%
2022	0.00	0%	0	$ 0.00	0.00%
2023	0.00	0%	0	$ 0.00	0.00%
2024	0.00	0%	0	$ 0.00	0.00%
2025	0.00	0%	0	$ 0.00	0.00%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10/yrs would be $ 0.00 with a yield on cost % of 0.00%
Rolling Last 4 qtrs dividends total $ 0.00 and Previous last 4 qtrs dividends total $ 0.00
Dividend 1 Yr Growth = ( 0.00 – 0.00 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection) 0.00

Year	Declaration Date	Ex-Dividend Date	Record Date	Payable Date	Dividend $ Amount
Total:					0.0000